• .

    161 Ft. Washington Avenue
    HIP 2
    New York, NY 10032

    Lisa Imundo, M.D.
    Associate Professor of Pediatrics (in Medicine)
    President-Elect of the American
    Academy of Pediatrics Executive Committee on Rheumatology
    Director of Adolescent Rheumatology
    New Director of Adolescent Rheumatology
    To make an appointment, please call: 212.305.4308
    Dr. Imundo has unparalleled experience in Pediatric and Adolescent Rheumatology, first as Chief of Pediatric Rheumatology for 17 years and now Chief of Adolescent Rheumatology.at Columbia University Medical Center. She currently represents Pediatric Rheumatology on the American Board of Pediatrics, the Committee of Pediatric Subspecialists and she is President-Elect of the American Academy of Pediatric Executive Committee on Pediatric Rheumatology.
    PRACTICE: Dr. Imundo is pleased to announce that she is expanding her practice beyond infants, children and teens to include young adults (to age 26), through a new transition program in Adolescent Rheumatology that she is founding in collaboration with the Department of Medicine. She will continue to see pediatric patients in familiar settings as well as in some new locations.

    Appointment times have been expanded in Downtown Manhattan, the Upper Eastside, Greenwich Hospital, Nyack Hospital, and Chappaqua–Northern Westchester Hospital as well as the main uptown Columbia University Medical Center Campus at NewYork Presbyterian (NYP) in the Irving Pavilion on the west corner of Fort Washington and 165th street. These facilities are well administered and efficient and appointments much easier to arrange.
    Please call (212) 305-4308 to make the next appointment without interruption in your care.
    HISTORY: Dr. Imundo's mentor Dr. Jerry Jacobs established Pediatric Rheumatology in 1960 at Columbia under the mentorship of the Chairman of Medicine, Charles Regan and the Chairman of Adult Rheumatology, Charles Christian. Dr. Jacobs wrote the first textbook in the field "Pediatric Rheumatology for the Practitioner" and defined new entities which today have genetic, cellular and molecular foundations. Dr. Jacobs' former fellows, among them, Dr. Imundo, wrote the continuing textbook "Arthritis in Children and Adolescents" (I. Szer, ed.).

    At Columbia University she was appointed both Division Director and Fellowship Director shortly after completing her Chief Residency and Fellowship. Under her leadership, her Division of Pediatric Rheumatology (1997-2014) expanded to provide care for thousands of children with complex and often mysterious Auto-Immune and Rheumatic diseases both on the inpatient and on the outpatient service, a record unmatched in the USA. She continues in the footsteps of Dr. Jacobs defining new entities and conducting cutting edge research in the efficacy of molecularly specific medications. Like Dr. Jacob's before her, Dr. Imundo is available continuously to treat the sick children of our Tri-State area, and like Dr. Jacob's before her, Dr. Imundo's patients become part of her family, and she very frequently part of theirs.
    PATIENT CARE EDUCATION AND RESEARCH: Dr. Imundo is recognized by her peers as an expert in the diagnosis and treatment of rheumatic diseases. Dr. Imundo has been the Primary Investigator or Co-Investigator for more than 40 studies. She was a charter member of the Childhood Arthritis and Rheumatology Alliance (CARRA) working on both their JIA and Lupus subcommittees. She is also an active participant in the Juvenile Dermatomyositis, Vasculitis, and Kawasaki’s Syndrome research consortiums. Dr. Imundo has mentored ten post-doctoral trainees. She was recently selected to the American Board of Pediatrics as a sub-board member and to the Committee for Pediatric Specialists to develop standards for Board Certification. Dr. Imundo has been active in the American College of Rheumatology and the American Academy of Pediatrics, and has worked in Government advocacy for children with rheumatic diseases.
    ACHIEVEMENTS AT COLUMBIA UNIVERSITY: Our patient population experiences dramatically less disability from Juvenile Arthritis than even ten years ago as a result of new therapies and the creation of an interdisciplinary care team at Columbia University. I championed and pioneered a number of innovative treatments including Alternate Day Steroid Therapy for children with Systemic Arthritis to protect growth, Sulfasalazine as a therapy for Juvenile Arthritis, IV Gammaglobulin for Juvenile Dermatomyositis, and high dose Infliximab for Systemic Arthritis and for Refractory Uveitis. Under my leadership, Columbia University was among the first medical centers to use biologic therapies in children and the first center in the United States to use Toclizimab in Systemic Arthritis (for a compassionate use trial). All of our trainees have continued these and other projects and have been successful in obtaining additional funding. Research mentors and collaborators have included Robert Winchester, Paul Rothman, Betty Diamond, Alessandra Pernis, Anne Davidson, Angela Cristiano, and Joan Bathon. With the creation of our center for Adolescent Rheumatology and renewed collaboration with Columbia’s leading immunologists Dr. Joan Bathon and Dr. Megan Sykes, we look forward to accelerated progress in the care of my Pediatric, Adolescent and Young Adults afflicted with Auto-Immune and Rheumatologic Diseases.

    Acknowledgements: I am indebted to my young patients who are my continuing inspiration and all my friends, colleagues and collaborators in the Pediatric Rheumatology community. I am also indebted to Michael Katz, John Driscoll Jr, Qais Al-Awqati, Ralph Blume, Robert Payette, Sylvia Griffiths, John N. Schullinger, Lucy Frank Squire, Suzanne Bowyer, Jennifer Bell, George Lazarus, and Isabel Jacobs.

  - Access Your Health Record Information
  - Request an Appointment
  - Renew a Prescription
  - Ask Questions
  - Receive Appointment Reminderscurrent

  - Please Note: version of the Patient Portal is only compatible with Google Chrome and Firefox